Home
Healthcare
Healthcare & Pharmaceuticals
Cerebral Palsy Market Size, Share & Growth | Forecast [2031]

Cerebral Palsy Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Types (Ataxia Cerebral Palsy, Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Athetoid Cerebral Palsy, Postnatal Cerebral Palsy, Congenital Cerebral Palsy, Hemiparesis of Cerebral Palsy, Hypotonic Cerebral Palsy, and Diplegia of Cerebral Palsy), Treatments (Surgery, Medication, and Therapy), Diagnosis (Laboratory Tests, Imaging Tests, and Others), Medical Devices (Orthotic Devices, ENT Devices, and Eye-tracking Devices), End-users (Physiotherapy Centers, Hospitals, Specialty Clinics, Home Care, Pathology Centers, Ambulatory, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

HC-4191
4.5 Rating
177 Pages

Upcoming
77 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

The global cerebral palsy market size was valued at USD 3.38 Billion in 2023 and is expected to surpass USD 4.53 Billion by 2031, expanding at a CAGR of 3.3% during the forecast period, 2023–2031. The growth of the market is attributed to the rising healthcare expenditure for the infant population and availability of advanced treatment devices of cerebral palsy.

Cerebral palsy refers to a neurological disorder that primarily affects the coordination of body movement of an infant due to imbalance brain development before birth, during birth, or after birth. The disorder is widely prevailed among the infant population. An infant with the disorder has incapable to walk independently and unstable walking patterns due to disturbance in body balance, body motion, and body posture. Patients with cerebral palsy show symptoms of various physical disabilities and impairment such as vision or hearing impairment and seizures besides a severe case of intellectual impairment. It is primary caused by the immature brain development after birth or other factors such as severe jaundice, bleeding into the brain, and brain infections of an infant. Without a proper and timely treatment or therapy, a patient may result to permanent paralysis.

The number of patients suffering from the disorder is higher in developed countries. As per the report by the Cerebral Palsy Guidance, around 10,000 babies are born with cerebral palsy each year in the US. According to the data published by the National Institute for Health and Care Excellence (NICE) in 2017, nearly 1 in 400 babies are born with the cerebral palsy in the UK and approximately around 1,800 infants are diagnosed with the disorder every year. The COVID-19 pandemic had adversely affected the market due to increasing decline of the patients visit to hospitals for the treatment as the majority of healthcare organizations were totally focused on handling the virus spreading.

Market Trends, Drivers, Restraints, and Opportunities

High prevalence of cerebral palsy among infants, especially in developed countries present a key factor driving the market.
Rising awareness among parents about the medications and advanced treatment methods for the disorder are expected to fuel the market in the coming years.
High spending on the healthcare sector and wide availability for insurance coverage for the disease treatment further boost the market.
High cost of the device treatment and some side effects of using treatment medications are the main restraining factors that can hamper the market.
Extensive R&D programs and technology development for the development of innovative medicines and devices are projected to create several growth opportunities for the market during the forecast period.

Scope of the Report

The report on the global cerebral palsy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Cerebral Palsy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Types (Ataxia Cerebral Palsy, Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Athetoid Cerebral Palsy, Postnatal Cerebral Palsy, Congenital Cerebral Palsy, Hemiparesis of Cerebral Palsy, Hypotonic Cerebral Palsy, and Diplegia of Cerebral Palsy), Treatments (Surgery, Medication, and Therapy), Diagnosis (Laboratory Tests, Imaging Tests, and Others), Medical Devices (Orthotic Devices, ENT Devices, and Eye-tracking Devices), End-users (Physiotherapy Centers, Hospitals, Specialty Clinics, Home Care, Pathology Centers, Ambulatory, and Others)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Abbott Laboratories; Allergen Plc; Merck & Co., Inc.; Medtronic PLC; Cellular Biomedicine Group; GlaxoSmithKline Plc; Cell Cure Neurosciences Ltd.; Acorda Therapeutics, Inc.; Meridigen Biotech Co., Ltd.; GW Pharmaceuticals Plc; and Pfizer, Inc.

Market Segment Insights

Spastic cerebral palsy segment to expand at a rapid pace

Based on types, the global cerebral palsy market is divided into ataxia cerebral palsy, spastic cerebral palsy, dyskinetic cerebral palsy, athetoid cerebral palsy, postnatal cerebral palsy, congenital cerebral palsy, hemiparesis of cerebral palsy, hypotonic cerebral palsy, and diplegia of cerebral palsy. The spastic cerebral segment is expected to expand at a rapid pace during the forecast period as it is the most common type of the disorder occurred among the infants. As per global health reports, spastic cerebral type accounts for nearly 77% of all cerebral palsy cases worldwide.

Wide availability of treatment drugs fuels the medication segment

In terms of treatments, the market is segmented into surgery, medication, and therapy. The medication segment accounted for a large market share in 2021 and is anticipated to hold a key share of the market in the coming years owing to wide availability of drugs such as muscle relaxants drugs, anti-depressants drugs, anti-convulsant drugs, anti-inflammatory drugs, and anti-spastic drugs. Medication remains a key component of the disorder treatment as parents usually prefer to adopt medication treatment first. The options for therapy and surgery are generally considered after the medication treatment of the disorder is not improving or working with the patients.

Increasing demand for MRI, CT, and EEG boosts the imaging tests segment

On the basis of diagnosis, the global cerebral palsy market is classified as laboratory tests, imaging tests, and others. The imaging tests segment is anticipated to expand at a rapid pace during the forecast period owing to increasing demand for magnetic resonance imaging (MRI), computerized tomography (CT); ultrasound, and electroencephalogram (EEG). Moreover, the wide popularity of the imaging tests in diagnostic purposes due to its certain benefits such as accurate diagnostic results present another key driver of the segment.

ENT devices segment to exhibit a robust growth rate

Based on medical devices, the market is categorized as orthotic devices, ENT devices, and eye-tracking devices. The ENT devices segment accounted for a large market share in 2021 and is anticipated to exhibit a robust growth rate during the forecast period owing to rising demand for electronic communication boards and other ENT devices such as hearing aids and implants.

Rising patients’ admission to hospitals propels the hospitals segment

On the basis of end-users, the global cerebral palsy market is segregated into physiotherapy centers, hospitals, specialty clinics, home care, pathology centers, ambulatory, and others. The hospitals segment is projected to register a considerable CAGR during the forecast period owing to high admission of the patients to hospitals due to the wide availability of advanced treatment devices and the presence of specialized doctors for the disorder.

North America to constitute a key market share

In terms of regions, the global cerebral palsy market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share, representing more than 37% share of the total revenue of the market in 2021 and is expected to constitute a key share of the market during the projected period owing to high prevalence of the disorder among a large portion of the infant population, rising adoption of novel treatment devices, and increasing spending on health-related issues. Moreover, the presence of well-established healthcare infrastructure and favorable reimbursement policies from medical insurance companies further drive the regional market.

Segments

The global cerebral palsy market has been segmented on the basis of

Types

Ataxia Cerebral Palsy
Spastic Cerebral Palsy
Dyskinetic Cerebral Palsy
Athetoid Cerebral Palsy
Postnatal Cerebral Palsy
Congenital Cerebral Palsy
Hemiparesis of Cerebral Palsy
Hypotonic Cerebral Palsy
Diplegia of Cerebral Palsy

Treatments

Surgery
Medication
Therapy

Diagnosis

Laboratory Tests
Imaging Tests
Others

Medical Devices

Orthotic Devices
ENT Devices
Eye-tracking Devices

End-users

Physiotherapy Centers
Hospitals
Specialty Clinics
Home Care
Pathology Centers
Ambulatory
Others

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Abbott Laboratories
Allergen Plc
Merck & Co., Inc.
Medtronic PLC
Cellular Biomedicine Group
GlaxoSmithKline Plc
Cell Cure Neurosciences Ltd.
Acorda Therapeutics, Inc.
Meridigen Biotech Co., Ltd.
GW Pharmaceuticals Plc
Pfizer, Inc.

Competitive Landscape

Key players competing in the global cerebral palsy market are Abbott Laboratories; Allergen Plc; Merck & Co., Inc.; Medtronic PLC; Cellular Biomedicine Group; GlaxoSmithKline Plc; Cell Cure Neurosciences Ltd.; Acorda Therapeutics, Inc.; Meridigen Biotech Co., Ltd.; GW Pharmaceuticals Plc; and Pfizer, Inc. Some of these players have adopted a series of business development strategies including merger and acquisition, entering into partnership and collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cerebral Palsy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cerebral Palsy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cerebral Palsy Market - Supply Chain
  4.5. Global Cerebral Palsy Market Forecast
     4.5.1. Cerebral Palsy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cerebral Palsy Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Cerebral Palsy Market Absolute $ Opportunity
5. Global Cerebral Palsy Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Cerebral Palsy Market Size and Volume Forecast by Types
     5.3.1. Ataxia Cerebral Palsy
     5.3.2. Spastic Cerebral Palsy
     5.3.3. Dyskinetic Cerebral Palsy
     5.3.4. Athetoid Cerebral Palsy
     5.3.5. Postnatal Cerebral Palsy
     5.3.6. Congenital Cerebral Palsy
     5.3.7. Hemiparesis of Cerebral Palsy
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cerebral Palsy Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Cerebral Palsy Market Size and Volume Forecast by End Users
     6.3.1. Physiotherapy Centers
     6.3.2. Hospitals
     6.3.3. Specialty Clinics
     6.3.4. Home Care
     6.3.5. Pathology Centers
     6.3.6. Ambulatory
     6.3.7. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Cerebral Palsy Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Cerebral Palsy Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Cerebral Palsy Demand Share Forecast, 2019-2026
8. North America Cerebral Palsy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Cerebral Palsy Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Cerebral Palsy Market Size and Volume Forecast by Types
     8.4.1. Ataxia Cerebral Palsy
     8.4.2. Spastic Cerebral Palsy
     8.4.3. Dyskinetic Cerebral Palsy
     8.4.4. Athetoid Cerebral Palsy
     8.4.5. Postnatal Cerebral Palsy
     8.4.6. Congenital Cerebral Palsy
     8.4.7. Hemiparesis of Cerebral Palsy
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Cerebral Palsy Market Size and Volume Forecast by End Users
     8.7.1. Physiotherapy Centers
     8.7.2. Hospitals
     8.7.3. Specialty Clinics
     8.7.4. Home Care
     8.7.5. Pathology Centers
     8.7.6. Ambulatory
     8.7.7. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Cerebral Palsy Demand Share Forecast, 2019-2026
9. Latin America Cerebral Palsy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Cerebral Palsy Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Cerebral Palsy Market Size and Volume Forecast by Types
     9.4.1. Ataxia Cerebral Palsy
     9.4.2. Spastic Cerebral Palsy
     9.4.3. Dyskinetic Cerebral Palsy
     9.4.4. Athetoid Cerebral Palsy
     9.4.5. Postnatal Cerebral Palsy
     9.4.6. Congenital Cerebral Palsy
     9.4.7. Hemiparesis of Cerebral Palsy
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Cerebral Palsy Market Size and Volume Forecast by End Users
     9.7.1. Physiotherapy Centers
     9.7.2. Hospitals
     9.7.3. Specialty Clinics
     9.7.4. Home Care
     9.7.5. Pathology Centers
     9.7.6. Ambulatory
     9.7.7. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Cerebral Palsy Demand Share Forecast, 2019-2026
10. Europe Cerebral Palsy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Cerebral Palsy Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Cerebral Palsy Market Size and Volume Forecast by Types
     10.4.1. Ataxia Cerebral Palsy
     10.4.2. Spastic Cerebral Palsy
     10.4.3. Dyskinetic Cerebral Palsy
     10.4.4. Athetoid Cerebral Palsy
     10.4.5. Postnatal Cerebral Palsy
     10.4.6. Congenital Cerebral Palsy
     10.4.7. Hemiparesis of Cerebral Palsy
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Cerebral Palsy Market Size and Volume Forecast by End Users
     10.7.1. Physiotherapy Centers
     10.7.2. Hospitals
     10.7.3. Specialty Clinics
     10.7.4. Home Care
     10.7.5. Pathology Centers
     10.7.6. Ambulatory
     10.7.7. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Cerebral Palsy Demand Share Forecast, 2019-2026
11. Asia Pacific Cerebral Palsy Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Cerebral Palsy Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Cerebral Palsy Market Size and Volume Forecast by Types
     11.4.1. Ataxia Cerebral Palsy
     11.4.2. Spastic Cerebral Palsy
     11.4.3. Dyskinetic Cerebral Palsy
     11.4.4. Athetoid Cerebral Palsy
     11.4.5. Postnatal Cerebral Palsy
     11.4.6. Congenital Cerebral Palsy
     11.4.7. Hemiparesis of Cerebral Palsy
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Cerebral Palsy Market Size and Volume Forecast by End Users
     11.7.1. Physiotherapy Centers
     11.7.2. Hospitals
     11.7.3. Specialty Clinics
     11.7.4. Home Care
     11.7.5. Pathology Centers
     11.7.6. Ambulatory
     11.7.7. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Cerebral Palsy Demand Share Forecast, 2019-2026
12. Middle East & Africa Cerebral Palsy Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Cerebral Palsy Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Cerebral Palsy Market Size and Volume Forecast by Types
     12.4.1. Ataxia Cerebral Palsy
     12.4.2. Spastic Cerebral Palsy
     12.4.3. Dyskinetic Cerebral Palsy
     12.4.4. Athetoid Cerebral Palsy
     12.4.5. Postnatal Cerebral Palsy
     12.4.6. Congenital Cerebral Palsy
     12.4.7. Hemiparesis of Cerebral Palsy
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Cerebral Palsy Market Size and Volume Forecast by End Users
     12.7.1. Physiotherapy Centers
     12.7.2. Hospitals
     12.7.3. Specialty Clinics
     12.7.4. Home Care
     12.7.5. Pathology Centers
     12.7.6. Ambulatory
     12.7.7. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Cerebral Palsy Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Cerebral Palsy Market: Market Share Analysis
  13.2. Cerebral Palsy Distributors and Customers
  13.3. Cerebral Palsy Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Abbott Laboratories
     13.4.2. Allergen Plc
     13.4.3. Merck & Co., Inc.
     13.4.4. Medtronic PLC
     13.4.5. Cellular Biomedicine Group
     13.4.6. GlaxoSmithKline Plc
     13.4.7. Cell Cure Neurosciences Ltd.
     13.4.8. Acorda Therapeutics

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked questions about this report!

1. Who are the key players competing in the global cerebral palsy market?

The key players of the market are Abbott Laboratories; Allergen Plc; Merck & Co., Inc.; Medtronic PLC; Cellular Biomedicine Group; GlaxoSmithKline Plc; Cell Cure Neurosciences Ltd.; Acorda Therapeutics, Inc.; Meridigen Biotech Co., Ltd.; GW Pharmaceuticals Plc; and Pfizer, Inc.